CABS1 | Calcium-binding protein, spermatid-specific 1 | | | | | | Tissue enriched |
PRR4 | Proline rich 4 (lacrimal) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
VCY1B | Variable charge, Y-linked 1B | | | | | | Tissue enriched |
VCY | Variable charge, Y-linked | | | | | | Tissue enriched |
PLA2G1B | Phospholipase A2, group IB (pancreas) | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
PRSS54 | Protease, serine, 54 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
RHOXF2 | Rhox homeobox family, member 2 | Transcription factors
| | | | | Tissue enriched |
MAGEC2 | Melanoma antigen family C, 2 | Cancer-related genes
| | | | | Tissue enriched |
C3orf22 | Chromosome 3 open reading frame 22 | | | | | | Tissue enriched |
IZUMO2 | IZUMO family member 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
TSPYL6 | TSPY-like 6 | | | | | | Tissue enriched |
DEFA5 | Defensin, alpha 5, Paneth cell-specific | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PRSS1 | Protease, serine, 1 (trypsin 1) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
SUN5 | Sad1 and UNC84 domain containing 5 | Predicted membrane proteins
| | | | | Tissue enriched |
FAM71B | Family with sequence similarity 71, member B | | | | | | Tissue enriched |
TMCO5A | Transmembrane and coiled-coil domains 5A | Predicted membrane proteins
| | | | | Tissue enriched |
CGB8 | Chorionic gonadotropin, beta polypeptide 8 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB5 | Chorionic gonadotropin, beta polypeptide 5 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
VCX3A | Variable charge, X-linked 3A | | | | | | Tissue enriched |
MYH4 | Myosin, heavy chain 4, skeletal muscle | Plasma proteins
| | | | | Tissue enriched |
PNLIP | Pancreatic lipase | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CPB1 | Carboxypeptidase B1 (tissue) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DEFA6 | Defensin, alpha 6, Paneth cell-specific | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SELM | Selenoprotein M | Predicted secreted proteins
| | | | | Tissue enriched |
SPERT | Spermatid associated | | | | | | Tissue enriched |
TEX19 | Testis expressed 19 | | | | | | Tissue enriched |
SLCO6A1 | Solute carrier organic anion transporter family, member 6A1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
FGB | Fibrinogen beta chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOH | Apolipoprotein H (beta-2-glycoprotein I) | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AQP12B | Aquaporin 12B | Predicted membrane proteins
| | | | | Tissue enriched |
DMRTB1 | DMRT-like family B with proline-rich C-terminal, 1 | Transcription factors
| | | | | Tissue enriched |
VCX | Variable charge, X-linked | | | | | | Tissue enriched |
PASD1 | PAS domain containing 1 | | | | | | Tissue enriched |
SYCP1 | Synaptonemal complex protein 1 | Plasma proteins
| | | | | Tissue enriched |
SAA4 | Serum amyloid A4, constitutive | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CPA2 | Carboxypeptidase A2 (pancreatic) | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
TSHR | Thyroid stimulating hormone receptor | Cancer-related genes Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ZPBP2 | Zona pellucida binding protein 2 | Predicted secreted proteins
| | | | | Tissue enriched |
KRT1 | Keratin 1 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Tissue enriched |
SPACA1 | Sperm acrosome associated 1 | Predicted membrane proteins
| | | | | Tissue enriched |
HBD | Hemoglobin, delta | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
TPTE | Transmembrane phosphatase with tensin homology | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
SYCP3 | Synaptonemal complex protein 3 | Disease related genes
| | | | | Tissue enriched |
UBE2U | Ubiquitin-conjugating enzyme E2U (putative) | Enzymes
| | | | | Tissue enriched |
CDSN | Corneodesmosin | Predicted secreted proteins
| | | | | Tissue enriched |
FGA | Fibrinogen alpha chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
MMP8 | Matrix metallopeptidase 8 (neutrophil collagenase) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SMC1B | Structural maintenance of chromosomes 1B | | | | | | Tissue enriched |
TYR | Tyrosinase | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |